Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs35156922 | chr2:178799893 | C/T | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs35209994 | chr22:18462871 | AG/A | 1.49E-7 | 494 | 30.8 | 31.9 | 27.37 | KM Plot |
PRAD | rs35211242 | chr22:23482483 | G/A | 7.39E-8 | 490 | 31.18 | 29.05 | 9.65 | KM Plot |
PRAD | rs35228404 | chr11:24246864 | A/G | 0.000162 | 492 | 30.87 | 32.9 | 20.47 | KM Plot |
PRAD | rs35267683 | chr2:178796796 | T/C | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs35267698 | chr2:178788758 | A/G | 4.16E-5 | 493 | 30.8 | 31.93 | 20.48 | KM Plot |
PRAD | rs35269654 | chr6:15490491 | A/AT | 3.21E-5 | 492 | 30.8 | 31.93 | 29.25 | KM Plot |
PRAD | rs35276197 | chr2:131716846 | T/C | 4.8E-5 | 487 | 31.23 | 31.25 | 20.12 | KM Plot |
PRAD | rs35277317 | chr2:178797498 | C/G | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs35278384 | chr7:43571280 | A/G | 7.72E-6 | 485 | 31.33 | 30.97 | 14.4 | KM Plot |
PRAD | rs35290239 | chr8:71931016 | A/T | 4.06E-5 | 494 | 31.18 | 29.97 | 24.27 | KM Plot |
PRAD | rs35291651 | chr7:6777369 | T/C | 3.63E-5 | 490 | 31 | 30.2 | 35.28 | KM Plot |
PRAD | rs35292362 | chr22:18449644 | A/AG | 2.94E-6 | 489 | 30.8 | 31.9 | 27.08 | KM Plot |
PRAD | rs35292793 | chr17:62992632 | T/C | 1.04E-8 | 481 | 30.87 | 31.62 | 19.63 | KM Plot |
PRAD | rs35300203 | chr4:189963721 | A/G | 2.18E-9 | 478 | 31.43 | 28.57 | 28.77 | KM Plot |